{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:06:45Z","timestamp":1782364005237,"version":"3.54.5"},"reference-count":39,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"unspecified","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009128","name":"Research for Patient Benefit Programme","doi-asserted-by":"publisher","award":["PB-PG-1216-20020"],"award-info":[{"award-number":["PB-PG-1216-20020"]}],"id":[{"id":"10.13039\/501100009128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2024,12,5]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Breathlessness is common and impairs the quality of life of people with idiopathic pulmonary fibrosis (IPF) and non-IPF fibrotic interstitial lung diseases (ILD). We report the findings of a multicentre, fast-track (wait-list), mixed-methods, randomised controlled, feasibility study of a complex breathlessness intervention in breathless IPF and non-IPF fibrotic ILD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Breathless IPF and non-IPF fibrotic ILD patients were randomised to receive the intervention within 1\u2009week (fast-track) or after 8\u2009weeks (wait-list). The intervention comprised two face-to-face and one telephone appointment during a 3-week period covering breathing control, handheld fan-use, pacing and breathlessness management techniques, and techniques to manage anxiety. Feasibility and clinical outcomes were assessed to inform progression to, and optimal design for, a definitive trial. A qualitative substudy explored barriers and facilitators to trial and intervention delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>47 patients (M:F 38:9, mean (SD) age 73.9 (7.2)) were randomised with a recruitment rate of 2.5 participants per month across three sites. The adjusted mean differences (95%\u2009CI) for key clinical outcomes at 4\u2009weeks post randomisation were as follows: Chronic Respiratory Questionnaire breathlessness mastery domain (0.45 (\u22120.07, 0.97)); and numerical rating scales for \u2018worst\u2019 (\u22120.93 (\u22121.95, 0.10)), \u2018best\u2019 (\u22120.19 (\u22121.38, 1.00)), \u2018distress caused by\u2019 (\u22121.84 (\u22123.29, \u20130.39)) and \u2018ability to cope with\u2019 (0.71 (\u22120.57, 1.99)) breathlessness within the past 24 hours. The qualitative substudy confirmed intervention acceptability and informed feasibility and acceptability of study outcome measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A definitive trial of a complex breathlessness intervention in patients with IPF and non-IPF fibrotic ILD is feasible with preliminary data supporting intervention effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN13784514\">ISRCTN13784514<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2024-002327","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T12:46:17Z","timestamp":1742647577000},"page":"e002327","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): a feasibility, wait-list design randomised controlled trial"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"isrctn13784514","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6876-0258","authenticated-orcid":false,"given":"Michael George","family":"Crooks","sequence":"first","affiliation":[{"name":"Respiratory Research Group, Hull York Medical School, Cottingham, East Yorkshire, UK"},{"name":"Hull University Teaching Hospitals NHS Trust, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-5270","authenticated-orcid":false,"given":"Caroline","family":"Wright","sequence":"additional","affiliation":[{"name":"Respiratory Research Group, Hull York Medical School, Cottingham, East Yorkshire, UK"},{"name":"Hull University Teaching Hospitals NHS Trust, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Hart","sequence":"additional","affiliation":[{"name":"Respiratory Research Group, Hull York Medical School, Cottingham, East Yorkshire, UK"},{"name":"Hull University Teaching Hospitals NHS Trust, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Allgar","sequence":"additional","affiliation":[{"name":"Plymouth University, Plymouth, Plymouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"English","sequence":"additional","affiliation":[{"name":"NHS Humber Foundation Trust, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7723-5244","authenticated-orcid":false,"given":"Flavia","family":"Swan","sequence":"additional","affiliation":[{"name":"Hull York Medical School, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Dyson","sequence":"additional","affiliation":[{"name":"Hull York Medical School, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Richardson","sequence":"additional","affiliation":[{"name":"Centre for Health Economics, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Twiddy","sequence":"additional","affiliation":[{"name":"Hull York Medical School, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Cohen","sequence":"additional","affiliation":[{"name":"Hull York Medical School, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Simpson","sequence":"additional","affiliation":[{"name":"University of Hull, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Huang","sequence":"additional","affiliation":[{"name":"Hull York Medical School, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0925-7772","authenticated-orcid":false,"given":"Dominic L","family":"Sykes","sequence":"additional","affiliation":[{"name":"Respiratory Research Group, Hull York Medical School, Cottingham, East Yorkshire, UK"},{"name":"Hull University Teaching Hospitals NHS Trust, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Johnson","sequence":"additional","affiliation":[{"name":"Hull York Medical School, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"2026010701501312000_12.1.e002327.1","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-021-01879-6","article-title":"Progressive fibrosing interstitial lung disease: prevalence and clinical outcome","volume":"22","author":"Kwon","year":"2021","journal-title":"Respir Res"},{"key":"2026010701501312000_12.1.e002327.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"2026010701501312000_12.1.e002327.3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00005209"},{"key":"2026010701501312000_12.1.e002327.4","doi-asserted-by":"crossref","DOI":"10.1186\/s40169-017-0172-3","article-title":"Early clinical experiences with nintedanib in three UK tertiary interstitial lung disease centres","volume":"6","author":"Toellner","year":"2017","journal-title":"Clin Transl Med"},{"key":"2026010701501312000_12.1.e002327.5","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-018-0651-3","article-title":"Symptom prevalence of patients with fibrotic interstitial lung disease: a systematic literature review","volume":"18","author":"Carvajalino","year":"2018","journal-title":"BMC Pulm Med"},{"key":"2026010701501312000_12.1.e002327.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2004.09.005"},{"key":"2026010701501312000_12.1.e002327.7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jpainsymman.2019.09.021","article-title":"Breathlessness, Anxiety, Depression, and Function-The BAD-F Study: A Cross-Sectional and Population Prevalence Study in Adults","volume":"59","author":"Currow","year":"2020","journal-title":"J Pain Symptom Manage"},{"key":"2026010701501312000_12.1.e002327.8","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00152609"},{"key":"2026010701501312000_12.1.e002327.9","first-page":"1","article-title":"Pulmonary Rehabilitation for Exercise Tolerance and Quality of Life in IPF Patients: A Systematic Review and Meta-Analysis","volume":"2019","author":"Yu","year":"2019","journal-title":"Biomed Res Int"},{"key":"2026010701501312000_12.1.e002327.10","unstructured":"NICE . Idiopathic pulmonary fibrosis in adults, 2015. Available: https:\/\/www.nice.org.uk\/guidance\/qs79\/chapter\/quality-statement-5-palliative-care"},{"key":"2026010701501312000_12.1.e002327.11","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-211589"},{"key":"2026010701501312000_12.1.e002327.12","doi-asserted-by":"publisher","DOI":"10.1177\/0269216319835393"},{"key":"2026010701501312000_12.1.e002327.13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2017-001330"},{"key":"2026010701501312000_12.1.e002327.14","doi-asserted-by":"crossref","DOI":"10.1136\/thoraxjnl-2016-209333.372","article-title":"P229\u2005Breath-taking outcomes: evaluation of a specialist breathlessness clinic","volume":"71","author":"Douglas","year":"2016","journal-title":"Thorax"},{"key":"2026010701501312000_12.1.e002327.15","doi-asserted-by":"publisher","DOI":"10.1177\/0269216311421835"},{"key":"2026010701501312000_12.1.e002327.16","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00186-2019","article-title":"A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol","volume":"5","author":"Wright","year":"2019","journal-title":"ERJ Open Res"},{"key":"2026010701501312000_12.1.e002327.17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S2213-2600(18)30289-3","article-title":"Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial","volume":"6","author":"Visca","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2026010701501312000_12.1.e002327.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-015-0453-x","article-title":"A randomised controlled trial of three or one breathing technique training sessions for breathlessness in people with malignant lung disease","volume":"13","author":"Johnson","year":"2015","journal-title":"BMC Med"},{"key":"2026010701501312000_12.1.e002327.19","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S2213-2600(14)70226-7","article-title":"An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial","volume":"2","author":"Higginson","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2026010701501312000_12.1.e002327.20","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-016-1304-6","article-title":"The clinical and cost effectiveness of a Breathlessness Intervention Service for patients with advanced non-malignant disease and their informal carers: mixed findings of a mixed method randomised controlled trial","volume":"17","author":"Farquhar","year":"2016","journal-title":"Trials"},{"key":"2026010701501312000_12.1.e002327.21","doi-asserted-by":"crossref","DOI":"10.1186\/1472-684X-9-22","article-title":"Effectiveness of a hand-held fan for breathlessness: a randomised phase II trial","volume":"9","author":"Bausewein","year":"2010","journal-title":"BMC Palliat Care"},{"key":"2026010701501312000_12.1.e002327.22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jpainsymman.2015.11.026","article-title":"A Mixed-Methods, Randomized, Controlled Feasibility Trial to Inform the Design of a Phase III Trial to Test the Effect of the Handheld Fan on Physical Activity and Carer Anxiety in Patients With Refractory Breathlessness","volume":"51","author":"Johnson","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"2026010701501312000_12.1.e002327.23","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-014-0194-2","article-title":"Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial","volume":"12","author":"Farquhar","year":"2014","journal-title":"BMC Med"},{"key":"2026010701501312000_12.1.e002327.24","article-title":"Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases","volume":"2008","author":"Bausewein","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"2026010701501312000_12.1.e002327.25","doi-asserted-by":"publisher","DOI":"10.1136\/thx.49.5.465"},{"key":"2026010701501312000_12.1.e002327.26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4037\/ajcc1998.7.3.200","article-title":"Validity of the numeric rating scale as a measure of dyspnea","volume":"7","author":"Gift","year":"1998","journal-title":"Am J Crit Care"},{"key":"2026010701501312000_12.1.e002327.27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jpainsymman.2019.06.004","article-title":"To What Extent Do the NRS and CRQ Capture Change in Patients\u2019 Experience of Breathlessness in Advanced Disease? Findings From a Mixed-Methods Double-Blind Randomized Feasibility Trial","volume":"58","author":"Lovell","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"2026010701501312000_12.1.e002327.28","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02089-2015"},{"key":"2026010701501312000_12.1.e002327.29","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02202-2019","article-title":"Minimal clinically important differences in average, best, worst and current intensity and unpleasantness of chronic breathlessness","volume":"56","author":"Ekstr\u00f6m","year":"2020","journal-title":"Eur Respir J"},{"key":"2026010701501312000_12.1.e002327.30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12931-021-01853-2","article-title":"Validation of a derived version of the IPF-specific Saint George\u2019s Respiratory Questionnaire","volume":"22","author":"Prior","year":"2021","journal-title":"Respir Res"},{"key":"2026010701501312000_12.1.e002327.31","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9903-x"},{"key":"2026010701501312000_12.1.e002327.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(01)00296-3"},{"key":"2026010701501312000_12.1.e002327.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2013.05.006"},{"key":"2026010701501312000_12.1.e002327.34","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00150314"},{"key":"2026010701501312000_12.1.e002327.35","doi-asserted-by":"publisher","DOI":"10.1097\/00005768-199805000-00021"},{"key":"2026010701501312000_12.1.e002327.36","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01499-2021","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic","year":"2022","journal-title":"Eur Respir J"},{"key":"2026010701501312000_12.1.e002327.37","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.2004.011155"},{"key":"2026010701501312000_12.1.e002327.38","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"2026010701501312000_12.1.e002327.39","doi-asserted-by":"publisher","DOI":"10.1080\/2159676x.2019.1628806"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2024-002327","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:50:29Z","timestamp":1767779429000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2024-002327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3,22]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bmjresp-2024-002327"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2024-002327","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}